Suppr超能文献

认知障碍、阿尔茨海默病及其他类型痴呆的筛查:欧洲照护者、支付方、医生和普通公众的观点。

Screening for cognitive impairment, Alzheimer's disease and other dementias: opinions of European caregivers, payors, physicians and the general public.

机构信息

Institute of Health and Society and Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.

出版信息

J Nutr Health Aging. 2010 Aug;14(7):558-62. doi: 10.1007/s12603-010-0268-6.

Abstract

The IMPACT survey queried physicians, caregivers, payors and members of the general public from 5 European countries (France, Germany, Italy, Spain and the United Kingdom) regarding their opinions towards screening for Alzheimer's disease (AD) as part of a 30-minute Web-based questionnaire conducted between April and May 2009. A larger proportion of caregivers (84%) and members of the general public (80%) than of physicians (56%) or payors (40%) viewed routine screening for AD as extremely or very important (P < 0.001 for caregivers or general public vs physicians or payors). When asked if everyone should be routinely screened for AD at age 65, a smaller proportion of physicians (42%) and payors (44%) than members of the general public (81%) or caregivers (80%) agreed (P < 0.001 for caregivers or general public vs physicians or payors). These opinions were generally consistent across the 5 countries for each respondent group. A notable exception was physician respondents from Italy, where most generalists and specialists actually favoured screening. Overall, generalists had a more positive attitude towards screening than specialists. The most frequently cited reason given by those who did not favour routine screening at age 65 was screening inaccuracy. This article discusses these results in relation to what screening is, when to screen and the barriers to screening. Despite the majority of IMPACT respondents being in favour of screening for AD, the evidence to support the introduction of population screening for cognitive impairment is not available; however, the importance of optimal identification of AD and other dementias in primary care should be a priority for community health professionals and payors. In order to do this effectively, further work is required to identify good assessment guidelines for use during opportunistic screening for cognitive impairment in primary care.

摘要

IMPACT 调查询问了来自 5 个欧洲国家(法国、德国、意大利、西班牙和英国)的医生、护理人员、支付者和普通公众对阿尔茨海默病(AD)筛查的看法,这是在 2009 年 4 月至 5 月期间进行的一项 30 分钟的基于网络的问卷的一部分。与医生(56%)或支付者(40%)相比,更多的护理人员(84%)和普通公众(80%)认为 AD 的常规筛查极其重要或非常重要(护理人员或普通公众与医生或支付者相比,P<0.001)。当被问及是否应该在 65 岁时对所有人进行 AD 的常规筛查时,与医生(42%)和支付者(44%)相比,普通公众(81%)和护理人员(80%)中只有较少的人同意(护理人员或普通公众与医生或支付者相比,P<0.001)。对于每个受访者群体,这些观点在 5 个国家之间基本一致。一个值得注意的例外是来自意大利的医生受访者,在那里,大多数普通医生和专家实际上赞成筛查。总的来说,普通医生对筛查的态度比专家更为积极。那些不赞成在 65 岁时进行常规筛查的人最常提到的原因是筛查不准确。本文将根据筛查的目的、何时进行筛查以及筛查的障碍来讨论这些结果。尽管大多数 IMPACT 受访者赞成 AD 的筛查,但支持对认知障碍进行人群筛查的证据尚不可用;然而,在初级保健中优化识别 AD 和其他痴呆症的重要性应该是社区卫生专业人员和支付者的优先事项。为了有效地做到这一点,需要进一步努力,以确定在初级保健中进行机会性认知障碍筛查时使用的良好评估指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验